Abbott India Ltd

1
BOM:500488 (India)  
₹ 27505.60 (+1.9%) Jun 7
47.86
P/B:
15.55
Market Cap:
₹ 584.47B ($ 7.00B)
Enterprise V:
₹ 563.02B ($ 6.74B)
Volume:
307.00
Avg Vol (2M):
453.00
Volume:
307.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Abbott India Ltd ( BOM:500488 ) from 1992 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Abbott India stock (BOM:500488) PE ratio as of Jun 07 2024 is 47.86. More Details

Abbott India Ltd (BOM:500488) PE Ratio (TTM) Chart

To

Abbott India Ltd (BOM:500488) PE Ratio (TTM) Historical Data

Total 1241
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Abbott India PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 48.7 2024-04-01 48.7
2024-06-07 48.7 2024-03-28 47.7
2024-06-06 47.8 2024-03-27 49.6
2024-06-05 48.6 2024-03-26 49.5
2024-06-04 46.5 2024-03-22 50.2
2024-06-03 45.9 2024-03-21 51.4
2024-05-31 45.8 2024-03-20 51.3
2024-05-29 46.2 2024-03-19 52.5
2024-05-28 45.9 2024-03-18 53.1
2024-05-27 46.4 2024-03-14 52.5
2024-05-24 46.4 2024-03-13 50.9
2024-05-23 46.1 2024-03-12 50.1
2024-05-22 46.3 2024-03-11 50.5
2024-05-21 46.8 2024-03-07 50.9
2024-05-17 46.9 2024-03-06 50.6
2024-05-16 47.0 2024-03-05 50.8
2024-05-15 46.8 2024-03-04 51.2
2024-05-14 47.4 2024-03-01 52.3
2024-05-13 47.8 2024-02-29 52.7
2024-05-10 46.6 2024-02-28 53.2
2024-05-09 45.2 2024-02-27 53.1
2024-05-08 45.9 2024-02-26 52.8
2024-05-07 45.5 2024-02-23 53.2
2024-05-06 45.6 2024-02-22 53.6
2024-05-03 46.3 2024-02-21 54.0
2024-05-02 47.1 2024-02-20 54.2
2024-04-30 46.7 2024-02-19 54.8
2024-04-29 46.5 2024-02-16 54.7
2024-04-26 45.8 2024-02-15 54.1
2024-04-25 45.4 2024-02-14 54.4
2024-04-24 45.0 2024-02-13 53.6
2024-04-23 45.5 2024-02-12 52.8
2024-04-22 46.5 2024-02-09 52.1
2024-04-19 46.2 2024-02-08 52.4
2024-04-18 46.1 2024-02-07 53.3
2024-04-16 46.2 2024-02-06 52.4
2024-04-15 46.3 2024-02-05 52.0
2024-04-12 46.8 2024-02-02 52.1
2024-04-10 47.9 2024-02-01 48.1
2024-04-09 46.7 2024-01-31 48.0
2024-04-08 46.7 2024-01-30 47.3
2024-04-05 47.1 2024-01-29 47.5
2024-04-04 47.1 2024-01-25 46.5
2024-04-03 47.3 2024-01-24 47.5
2024-04-02 48.2 2024-01-23 47.2

Abbott India Ltd (BOM:500488) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.